Protein-Centric Omics Analysis Reveals Circulating Complements Linked to Non-Viral Liver Diseases as Potential Therapeutic Targets

CONCLUSIONS: Our study suggests that certain complement components, including C1S, C1QC, CFHR1, CFHR2, CFHR5, C7, and C8G, might play a role in non-viral liver diseases and could be potential targets for drug development.PMID:38061333 | DOI:10.3350/cmh.2023.0343
Source: Clinical and molecular hepatology - Category: Gastroenterology Authors: Source Type: research